# Administrative Core

> **NIH NIH U19** · BRIGHAM AND WOMEN'S HOSPITAL · 2022 · $106,696

## Abstract

In response to a Funding Opportunity Announcement for multi-institutional teams to form a Glioblastoma 
Therapeutics Network (GTN) basic scientists and clinical/translational investigators from three institutions in 
the Dana-Farber/Harvard Cancer Center have joined forces with their counterparts in the Stanford Cancer 
Center to create the “Harvard/Stanford GTN”. The GTN study plan features three Projects an 
Administrative Core, a Pharmacological and Genomic Imaging Core and a proposed Network 
Coordinating Center (NCC). The Administrative Core will be based at Brigham and Women’s Hospital, the 
parent organization for the Harvard/Stanford GTN, and will serve as the coordinating center and hub for the 
four institutions comprising the program and all interactions with existing P30-supported resources for clinical 
trials. The core will coordinate internal and external components of this complex structure to foster and support 
multi-project, inter-disciplinary, and inter-institutional drug development research in adult glioblastoma. Core 
personnel include one GTN Principal Investigator, three Site Leads at the Harvard/Stanford GTN institutions, 
two scientific co-administrators, a program coordinator, two grants specialists, and an administrative assistant. 
There are five Specific Aims in the Administrative Core. In the First Aim, the core will develop and engage a 
multidisciplinary Internal Advisory Board to provide critical oversight of the overall Harvard/Stanford GTN 
program. In the Second Aim, the core will organize regular meetings of key stakeholders to foster 
collaboration, troubleshooting, and monitoring of progress. In the Third and Fourth Aims, the core will maintain 
a trans-institutional program for regular, internal and external electronic communication among 
Harvard/Stanford project and core co-leads, clinical trialists, the GTN Steering Committee, the NCC, NCI 
program officials, and industry partners. In the Fifth Aim, the core will engage with institutional leaders at 
Harvard and Stanford to promote diversity and inclusion throughout the Harvard/Stanford GTN program. The 
Administrative Core Leader, Tracy Batchelor, M.D., will serve as the overall Principal Investigator of the 
Harvard/Stanford GTN program with able assistance from Site Leads at Dana-Farber Cancer Institute (Patrick 
Wen, M.D.), Massachusetts General Hospital (Isabel Arrillaga, M.D., Ph.D.), and Stanford University (Michelle 
Monje, M.D., Ph.D.). This trans-institutional administrative team at Dana-Farber/Harvard Cancer Center and 
Stanford Cancer Center have worked together effectively on other multi-center, multi-project, NCI-sponsored
glioma research projects.

## Key facts

- **NIH application ID:** 10491820
- **Project number:** 5U19CA264504-02
- **Recipient organization:** BRIGHAM AND WOMEN'S HOSPITAL
- **Principal Investigator:** Tracy T Batchelor
- **Activity code:** U19 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $106,696
- **Award type:** 5
- **Project period:** 2021-09-21 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10491820

## Citation

> US National Institutes of Health, RePORTER application 10491820, Administrative Core (5U19CA264504-02). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10491820. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*